Journal metric profile

Journal of Drugs in Dermatology

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 1.800 2025 metric year
5-Year Impact Factor 1.900 Longer citation window
JCR Quartile Q3 Subject-category quartile
JCR Category Rank 56/96 Recorded category rank

Journal of Drugs in Dermatology JCR impact factor overview

This profile summarizes the journal metrics and publication information available in the current directory record.

Page reviewed August 6, 2026

Journal of Drugs in Dermatology metric snapshot

Journal of Drugs in Dermatology has a bibliometric profile in this directory for 2025. The publisher recorded for the journal is JOURNAL OF DRUGS IN DERMATOLOGY. Its listed Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor is 1.800. The five-year Journal Impact Factor is 1.900, giving a second citation window for comparison. The journal is recorded in quartile Q3 for its listed JCR category.

Category position and quartile

The recorded JCR category position is 56 out of 96 journals. Based on that rank position, the journal sits within approximately the top 58% of the listed category. Its listed quartile is Q3. Category ranks and quartiles are field-specific and are not measures of the quality of an individual article.

How the citation indicators compare

The five-year Journal Impact Factor (1.900) is 0.100 points higher than the standard Journal Impact Factor (1.800). Without journal self-citations, the Impact Factor is 1.600, a difference of 0.200 points from the listed standard value. The Journal Citation Indicator (JCI) is recorded as 0.600. These measures use different definitions or citation windows, so they are most useful when read together rather than treated as interchangeable scores.

Citation and publication counts

For 2025, the directory record for Journal of Drugs in Dermatology lists total cites: 4,433; total articles: 176; citable items: 186. These fields describe different parts of the JCR record and should not be combined into an article-level quality score.

Citation half-life profile

The cited half-life is 7.5 years, indicating the median age of items that contributed citations to the journal in the reporting framework. The citing half-life is 7.3 years, indicating the median age of references used by the journal’s articles.

Identifiers and verification

Journal of Drugs in Dermatology is identified in this directory by print ISSN 1545-9616 and electronic ISSN 1545-9616. The publisher is recorded as JOURNAL OF DRUGS IN DERMATOLOGY. When making submission, library, or research-evaluation decisions, verify the title and identifiers against the journal publisher and the official Clarivate Journal Citation Reports record.

Complete journal information

Use this table to verify the individual metric values, identifiers and publication details stored for this journal.

Journal nameJournal of Drugs in Dermatology
Abbreviated journalJ DRUGS DERMATOL
PublisherJOURNAL OF DRUGS IN DERMATOLOGY
Metric year2025
Overall rank9,201
ISSN1545-9616
eISSN1545-9616
Total cites4,433
Total articles176
Citable items186
Cited half-life7.5 years
Citing half-life7.3 years
JCR-based Journal Impact Factor1.800
5-Year Impact Factor1.900
Impact Factor without journal self-cites1.600
Journal Citation Indicator0.600
JCR Impact Factor quartileQ3
JCR category rank56/96
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of Journal of Drugs in Dermatology?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for Journal of Drugs in Dermatology is 1.800 for the 2025 metric year.

What are the JCR quartile and category rank of Journal of Drugs in Dermatology?

Journal of Drugs in Dermatology is listed with quartile Q3 and category rank 56/96. These values are category-specific and should be verified against the official JCR record when used for formal assessment.

What is the five-year Journal Impact Factor of Journal of Drugs in Dermatology?

The five-year Journal Impact Factor recorded for Journal of Drugs in Dermatology is 1.900. It uses a longer citation window than the standard Journal Impact Factor.

Who publishes Journal of Drugs in Dermatology?

Journal of Drugs in Dermatology is listed in this directory as being published by JOURNAL OF DRUGS IN DERMATOLOGY.

Additional records from the same publisher or with a similar listed JCR Impact Factor.